Home › Funds › CLARIS ADVISORS, LLC / MO / › JNJ

CLARIS ADVISORS, LLC / MO / position in JNJ

JOHNSON & JOHNSON · Health Care

CLARIS ADVISORS, LLC / MO / reported holding 1,914 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$507K, representing 0.14% of its reported portfolio and ranking #44 among its reported holdings. CLARIS ADVISORS, LLC / MO / has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.91K sh
Reported value held$506.71K
Portfolio Weight0.14%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CLARIS ADVISORS, LLC / MO /'s JNJ position evolved

CLARIS ADVISORS, LLC / MO / first disclosed a stake in JNJ in Q3 2023 at 1,503 shares (US$234K). The position peaked in Q1 2026 at 2,314 shares, worth US$566K. Across 13 filings, CLARIS ADVISORS, LLC / MO / increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 1,914 shares valued at US$507K. Notable position changes include a 38% increase in Q4 2024 (shares rose 12% over the following quarter), a 57% increase in Q2 2025 (shares rose 22% over the following quarter), a 32% trim in Q4 2025 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.50K $234.09K New
Q4 2023 1.50K $235.58K Hold
Q1 2024 1.50K $237.76K Hold
Q2 2024 1.42K $207.99K Reduce
Q3 2024 1.50K $242.28K Add
Q4 2024 2.06K $298.64K Add
Q1 2025 2.18K $362.03K Add
Q2 2025 3.44K $525.00K Add
Q3 2025 3.44K $525.00K Hold
Q4 2025 2.34K $483.85K Reduce
Q1 2026 2.31K $565.63K Reduce
Q2 2026 1.91K $486.10K Reduce
Q3 2026 1.91K $506.71K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has CLARIS ADVISORS, LLC / MO / held JNJ?

CLARIS ADVISORS, LLC / MO / has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CLARIS ADVISORS, LLC / MO /'s current position in JNJ?

As of Q3 2026, CLARIS ADVISORS, LLC / MO / holds 1.91K shares of JNJ (JOHNSON & JOHNSON), valued at $506.71K, representing 0.14% of its reported portfolio and ranking #44.

Has CLARIS ADVISORS, LLC / MO / been buying or selling JNJ?

In the latest 13F filing (Q3 2026), CLARIS ADVISORS, LLC / MO / held unchanged its position in JNJ. The position peaked in Q1 2026 at 2.31K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.